192 related articles for article (PubMed ID: 29467430)
1. Evaluation of Macaca radiata as a non-human primate model of Dengue virus infection.
Kato F; Ishida Y; Kawakami A; Takasaki T; Saijo M; Miura T; Hishiki T
Sci Rep; 2018 Feb; 8(1):3421. PubMed ID: 29467430
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans.
Moi ML; Takasaki T; Omatsu T; Nakamura S; Katakai Y; Ami Y; Suzaki Y; Saijo M; Akari H; Kurane I
J Gen Virol; 2014 Mar; 95(Pt 3):591-600. PubMed ID: 24323638
[TBL] [Abstract][Full Text] [Related]
3. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
[TBL] [Abstract][Full Text] [Related]
4. Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity.
Omatsu T; Moi ML; Hirayama T; Takasaki T; Nakamura S; Tajima S; Ito M; Yoshida T; Saito A; Katakai Y; Akari H; Kurane I
J Gen Virol; 2011 Oct; 92(Pt 10):2272-2280. PubMed ID: 21697346
[TBL] [Abstract][Full Text] [Related]
5. Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines.
Borges MB; Marchevsky RS; Carvalho Pereira R; da Silva Mendes Y; Almeida Mendes LG; Diniz-Mendes L; Cruz MA; Tahmaoui O; Baudart S; Freire M; Homma A; Schneider-Ohrum K; Vaughn DW; Vanloubbeeck Y; Lorin C; Malice MP; Caride E; Warter L
PLoS Pathog; 2019 Apr; 15(4):e1007721. PubMed ID: 31009499
[TBL] [Abstract][Full Text] [Related]
6. Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes.
Ito M; Katakai Y; Ono F; Akari H; Mukai RZ; Takasaki T; Kotaki A; Kurane I
Arch Virol; 2011 Jun; 156(6):1073-7. PubMed ID: 21409446
[TBL] [Abstract][Full Text] [Related]
7. Olive baboons: a non-human primate model for testing dengue virus type 2 replication.
Valdés I; Gil L; Castro J; Odoyo D; Hitler R; Munene E; Romero Y; Ochola L; Cosme K; Kariuki T; Guillén G; Hermida L
Int J Infect Dis; 2013 Dec; 17(12):e1176-81. PubMed ID: 24139794
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays.
Yamanaka A; Suzuki R; Konishi E
Vaccine; 2014 Jul; 32(34):4289-95. PubMed ID: 24950360
[TBL] [Abstract][Full Text] [Related]
9. Marmosets (Callithrix jacchus) as a non-human primate model for evaluation of candidate dengue vaccines: induction and maintenance of specific protective immunity against challenges with clinical isolates.
Moi ML; Ami Y; Muhammad Azami NA; Shirai K; Yoksan S; Suzaki Y; Kitaura K; Lim CK; Saijo M; Suzuki R; Takasaki T; Kurane I
J Gen Virol; 2017 Dec; 98(12):2955-2967. PubMed ID: 29160199
[TBL] [Abstract][Full Text] [Related]
10. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
[TBL] [Abstract][Full Text] [Related]
11. Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques.
McCracken MK; Gromowski GD; Garver LS; Goupil BA; Walker KD; Friberg H; Currier JR; Rutvisuttinunt W; Hinton KL; Christofferson RC; Mores CN; Vanloubbeeck Y; Lorin C; Malice MP; Thomas SJ; Jarman RG; Vaughn DW; Putnak JR; Warter L
PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008191. PubMed ID: 32267846
[TBL] [Abstract][Full Text] [Related]
12. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
[TBL] [Abstract][Full Text] [Related]
13. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
[TBL] [Abstract][Full Text] [Related]
14. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
[TBL] [Abstract][Full Text] [Related]
15. Virological and Immunological Outcomes in Rhesus Monkeys after Exposure to Dengue Virus-Infected
Carrington LB; Ponlawat A; Nitatsukprasert C; Khongtak P; Sunyakumthorn P; Ege CA; Im-Erbsin R; Chumpolkulwong K; Thaisomboonsuk B; Klungthong C; Yoon IK; Ellison D; Macareo L; Simmons CP
Am J Trop Med Hyg; 2020 Jul; 103(1):112-119. PubMed ID: 32431270
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
Budigi Y; Ong EZ; Robinson LN; Ong LC; Rowley KJ; Winnett A; Tan HC; Hobbie S; Shriver Z; Babcock GJ; Alonso S; Ooi EE
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006209. PubMed ID: 29425203
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention.
Goncalvez AP; Engle RE; St Claire M; Purcell RH; Lai CJ
Proc Natl Acad Sci U S A; 2007 May; 104(22):9422-7. PubMed ID: 17517625
[TBL] [Abstract][Full Text] [Related]
18. Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody.
Lai CJ; Goncalvez AP; Men R; Wernly C; Donau O; Engle RE; Purcell RH
J Virol; 2007 Dec; 81(23):12766-74. PubMed ID: 17881450
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of dengue and chikungunya virus strains circulating in New Delhi, India.
Afreen N; Deeba F; Khan WH; Haider SH; Kazim SN; Ishrat R; Naqvi IH; Shareef MY; Broor S; Ahmed A; Parveen S
Microbiol Immunol; 2014 Dec; 58(12):688-96. PubMed ID: 25346397
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).
Gelanew T; Hunsperger E
Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
